Dissecting the diverse functions of the metastasis suppressor CD82/KAI1

FEBS Letters

Volumn 585, Issue 20, 2011, Pages 3166-3173

  Tsai, Yien Che ^a   Weissman, Allan M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Duffy antigen receptor for chemokine (DARC); Endoplasmic reticulum associated degradation (ERAD); Epidermal growth factor receptor (EGFR); Exosome; gp78 RNF45; ubiquitin proteasome system (UPS)

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ALPHA6 INTEGRIN; BETA CATENIN; CD82 ANTIGEN; CRK ASSOCIATED SUBSTRATE PROTEIN; DUFFY BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; TETRASPANIN; UVOMORULIN;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN STRUCTURE; APOPTOSIS; CELL ADHESION; CELL AGGREGATION; CELL AGING; CELL COMMUNICATION; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELL SURVIVAL; EXOSOME; GENE OVEREXPRESSION; HUMAN; HYPOXIA; MEMBRANE STRUCTURE; METASTASIS; METASTASIS SUPPRESSOR GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; SUPPRESSOR GENE; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; ANTIGENS, CD82; APOPTOSIS; CELL AGING; CELL COMMUNICATION; CELL MEMBRANE; CELL MOVEMENT; CELL POLARITY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 80054079078     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.08.031     Document Type: Review

References (84)

1. J.T. Dong, P.W. Lamb, C.W. Rinker-Schaeffer, J. Vukanovic, T. Ichikawa, J.T. Isaacs, and J.C. Barrett KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2 Science 268 1995 884 886
2. S. Lebel-Binay, C. Lagaudriere, D. Fradelizi, and H. Conjeaud CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation J. Immunol. 155 1995 101 110
3. Y. Nojima The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion Cell. Immunol. 152 1993 249 260 (Pubitemid 23354824)
4. K. Fukudome, M. Furuse, T. Imai, M. Nishimura, S. Takagi, Y. Hinuma, and O. Yoshie Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells J. Virol. 66 1992 1394 1401
5. S. Lebel-Binay Further characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cells Cell. Immunol. 154 1994 468 483 (Pubitemid 24115147)
6. T. Imai, and O. Yoshie C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells J. Immunol. 151 1993 6470 6481 (Pubitemid 23340393)
7. S. Bandyopadhyay Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression Nat. Med. 12 2006 933 938 (Pubitemid 44175145)
8. Y.C. Tsai The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation Nat. Med. 13 2007 1504 1509 (Pubitemid 350224250)
9. J.H. Xu, X.Z. Guo, L.N. Ren, L.C. Shao, and M.P. Liu KAI1 is a potential target for anti-metastasis in pancreatic cancer cells World J. Gastroenterol. 14 2008 1126 1132
10. J.M. Yang, Z.H. Peng, S.H. Si, W.W. Liu, Y.H. Luo, and Z.Y. Ye KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models Liver Int. 28 2008 132 139
11. X. Yang, L.L. Wei, C. Tang, R. Slack, S. Mueller, and M.E. Lippman Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells Cancer Res. 61 2001 5284 5288 (Pubitemid 32681565)
12. H. Tonoli, and J.C. Barrett CD82 metastasis suppressor gene: a potential target for new therapeutics? Trends Mol. Med. 11 2005 563 570 (Pubitemid 41713998)
13. M. Seigneuret Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily Biophys. J. 90 2006 212 227
14. R. Bari, Y.H. Zhang, F. Zhang, N.X. Wang, C.S. Stipp, J.J. Zheng, and X.A. Zhang Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis Am. J. Pathol. 174 2009 647 660
15. M. Ono, K. Handa, D.A. Withers, and S. Hakomori Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation Cancer Res. 59 1999 2335 2339 (Pubitemid 29242279)
16. K. Kitadokoro, D. Bordo, G. Galli, R. Petracca, F. Falugi, S. Abrignani, G. Grandi, and M. Bolognesi CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs EMBO J. 20 2001 12 18 (Pubitemid 32099097)
17. M. Ono, K. Handa, D.A. Withers, and S. Hakomori Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells Biochem. Biophys. Res. Commun. 279 2000 744 750 (Pubitemid 32042851)
18. C.J. Scholz, G. Sauer, and H. Deissler Glycosylation of tetraspanin Tspan-1 at four distinct sites promotes its transition through the endoplasmic reticulum Protein Pept. Lett. 16 2009 1244 1248
19. B. Jee, K. Jin, J.H. Hahn, H.G. Song, and H. Lee Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway Exp. Mol. Med. 35 2003 30 37 (Pubitemid 36336926)
20. M. Abe, T. Sugiura, M. Takahashi, K. Ishii, M. Shimoda, and K. Shirasuna A novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells Cancer Lett. 266 2008 163 170
21. A. Takaoka, Y. Hinoda, S. Sato, F. Itoh, M. Adachi, M. Hareyama, and K. Imai Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells Jpn. J. Cancer Res. 89 1998 397 404 (Pubitemid 28226920)
22. A. Takaoka, Y. Hinoda, S. Satoh, Y. Adachi, F. Itoh, M. Adachi, and K. Imai Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene Oncogene 16 1998 1443 1453 (Pubitemid 28151851)
23. X.A. Zhang, B. He, B. Zhou, and L. Liu Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration J. Biol. Chem. 278 2003 27319 27328 (Pubitemid 36876890)
24. B.K. Jee, J.Y. Lee, Y. Lim, K.H. Lee, and Y.H. Jo Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells Biochem. Biophys. Res. Commun. 359 2007 703 708 (Pubitemid 46899009)
25. B.K. Jee, K.M. Park, S. Surendran, W.K. Lee, C.W. Han, Y.S. Kim, and Y. Lim KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line Biochem. Biophys. Res. Commun. 342 2006 655 661 (Pubitemid 43289040)
26. J.H. Lee, S.R. Park, K.O. Chay, Y.W. Seo, H. Kook, K.Y. Ahn, Y.J. Kim, and K.K. Kim KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer Cancer Res. 64 2004 4235 4243 (Pubitemid 38802428)
27. A.R. Todeschini, J.N. Dos Santos, K. Handa, and S.I. Hakomori Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse J. Biol. Chem. 282 2007 8123 8133 (Pubitemid 47093583)
28. B. He, L. Liu, G.A. Cook, S. Grgurevich, L.K. Jennings, and X.A. Zhang Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion J. Biol. Chem. 280 2005 3346 3354 (Pubitemid 40223797)
29. X.A. Zhang, W.S. Lane, S. Charrin, E. Rubinstein, and L. Liu EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells Cancer Res. 63 2003 2665 2674 (Pubitemid 36605211)
30. R.L. Klemke, J. Leng, R. Molander, P.C. Brooks, K. Vuori, and D.A. Cheresh CAS/Crk coupling serves as a "molecular switch" for induction of cell migration J. Cell Biol. 140 1998 961 972 (Pubitemid 28141232)
31. B. Zhou, L. Liu, M. Reddivari, and X.A. Zhang The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity Cancer Res. 64 2004 7455 7463 (Pubitemid 39372088)
32. E. Odintsova, T. Sugiura, and F. Berditchevski Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1 Curr. Biol. 10 2000 1009 1012
33. F. Berditchevski, and E. Odintsova Tetraspanins as regulators of protein trafficking Traffic 8 2007 89 96 (Pubitemid 46099996)
34. J.M. Escola, M.J. Kleijmeer, W. Stoorvogel, J.M. Griffith, O. Yoshie, and H.J. Geuze Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes J. Biol. Chem. 273 1998 20121 20127 (Pubitemid 28377568)
35. E. Odintsova, J. Voortman, E. Gilbert, and F. Berditchevski Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR J. Cell Sci. 116 2003 4557 4566 (Pubitemid 37461610)
36. X.Q. Wang, Q. Yan, P. Sun, J.W. Liu, L. Go, S.M. McDaniel, and A.S. Paller Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside Cancer Res. 67 2007 9986 9995 (Pubitemid 47621249)
37. S.C. Sridhar, and C.K. Miranti Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases Oncogene 25 2006 2367 2378
38. M. Takahashi, T. Sugiura, M. Abe, K. Ishii, and K. Shirasuna Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration Int. J. Cancer 121 2007 1919 1929 (Pubitemid 47463154)
39. J. Kalabis, I. Rosenberg, and D.K. Podolsky Vangl1 protein acts as a downstream effector of intestinal trefoil factor (ITF)/TFF3 signaling and regulates wound healing of intestinal epithelium J. Biol. Chem. 281 2006 6434 6441 (Pubitemid 43847575)
40. R. Bass, F. Werner, E. Odintsova, T. Sugiura, F. Berditchevski, and V. Ellis Regulation of urokinase receptor proteolytic function by the tetraspanin CD82 J. Biol. Chem. 280 2005 14811 14818 (Pubitemid 40562830)
41. C.C. Hu, F.X. Liang, G. Zhou, L. Tu, C.H. Tang, J. Zhou, G. Kreibich, and T.T. Sun Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking Mol. Biol. Cell 16 2005 3937 3950 (Pubitemid 41262868)
42. Y.C. Tsai, and A.M. Weissman The unfolded protein response, degradation from endoplasmic reticulum and cancer Genes Cancer 1 2010 764 778
43. C.Y. Wu Overexpression of KAI1 induces autophagy and increases MiaPaCa-2 cell survival through the phosphorylation of extracellular signal-regulated kinases Biochem. Biophys. Res. Commun. 404 2011 802 808
44. N. Schoenfeld, M.K. Bauer, and S. Grimm The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates FASEB J. 18 2004 158 160
45. V. Zismanov, M. Lishner, S. Tartakover-Matalon, J. Radnay, H. Shapiro, and L. Drucker Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling Br. J. Cancer 101 2009 1402 1409
46. C.L. Hammond, R. Marchan, S.M. Krance, and N. Ballatori Glutathione export during apoptosis requires functional multidrug resistance-associated proteins J. Biol. Chem. 282 2007 14337 14347 (Pubitemid 47100459)
47. T. Tohami, L. Drucker, H. Shapiro, J. Radnay, and M. Lishner Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential FASEB J. 21 2007 691 699 (Pubitemid 46348245)
48. H. Shen, R. Schuster, K.F. Stringer, S.E. Waltz, and A.B. Lentsch The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth FASEB J. 20 2006 59 64 (Pubitemid 43100476)
49. L. Xu, A. Ashkenazi, and A. Chaudhuri Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells Angiogenesis 10 2007 307 318 (Pubitemid 350045887)
50. J.K. Elson, J.L. Beebe-Dimmer, H. Morgenstern, M. Chilkuri, J. Blanchard, and A.B. Lentsch The Duffy antigen/receptor for chemokines (DARC) and prostate-cancer risk among Jamaican men J. Immigr. Minor. Health 13 2011 36 41
51. C. Thery, L. Zitvogel, and S. Amigorena Exosomes: composition, biogenesis and function Nat. Rev. Immunol. 2 2002 569 579 (Pubitemid 37328732)
52. A. Chairoungdua, D.L. Smith, P. Pochard, M. Hull, and M.J. Caplan Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling J. Cell Biol. 190 2010 1079 1091
53. J.H. Kim Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes Nature 434 2005 921 926 (Pubitemid 40559007)
54. K. Tagawa, K. Arihiro, Y. Takeshima, E. Hiyama, M. Yamasaki, and K. Inai Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma Jpn. J. Cancer Res. 90 1999 970 976 (Pubitemid 29500436)
55. J.T. Dong, H. Suzuki, S.S. Pin, G.S. Bova, J.A. Schalken, W.B. Isaacs, J.C. Barrett, and J.T. Isaacs Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss Cancer Res. 56 1996 4387 4390 (Pubitemid 26330445)
56. F.S. Liu, J.T. Dong, J.T. Chen, Y.T. Hsieh, E.S. Ho, and M.J. Hung Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma Gynecol. Oncol. 78 2000 10 15 (Pubitemid 30439471)
57. T. Miyazaki Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma Cancer 89 2000 955 962
58. P. Jackson, D. Millar, E. Kingsley, G. Yardley, K. Ow, S. Clark, and P.J. Russell Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines Cancer Lett. 157 2000 169 176 (Pubitemid 30629028)
59. A.C. Gao, W. Lou, J.T. Dong, J.C. Barrett, D. Danielpour, and J.T. Isaacs Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene Prostate 57 2003 256 260 (Pubitemid 37487070)
60. A. Marreiros, K. Dudgeon, V. Dao, M.O. Grimm, R. Czolij, M. Crossley, and P. Jackson KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells Oncogene 24 2005 637 649 (Pubitemid 40188568)
61. T. Mashimo, S. Bandyopadhyay, G. Goodarzi, M. Watabe, S.K. Pai, S.C. Gross, and K. Watabe Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes Biochem. Biophys. Res. Commun. 274 2000 370 376 (Pubitemid 30614325)
62. T. Mashimo, M. Watabe, S. Hirota, S. Hosobe, K. Miura, P.J. Tegtmeyer, C.W. Rinker-Shaeffer, and K. Watabe The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53 Proc. Natl. Acad. Sci. USA 95 1998 11307 11311 (Pubitemid 28450124)
63. B. Gellersen Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: regulation and functional implications Am. J. Pathol. 170 2007 126 139 (Pubitemid 47339194)
64. S. Sigala, I. Faraoni, D. Botticini, M. Paez-Pereda, C. Missale, E. Bonmassar, and P. Spano Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines Clin. Cancer Res. 5 1999 1211 1218 (Pubitemid 29233240)
65. H. Akita, A. Iizuka, Y. Hashimoto, K. Kohri, K. Ikeda, and M. Nakanishi Induction of KAI-1 expression in metastatic cancer cells by phorbol esters Cancer Lett. 153 2000 79 83 (Pubitemid 30209847)
66. P. Jackson, M.O. Grimm, E.A. Kingsley, U. Brosius, T. Antalis, G. Yardley, and P.J. Russell Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines Urol. Oncol. 7 2002 99 104
67. P. Jackson, K. Ow, G. Yardley, W. Delprado, D.I. Quinn, J.L. Yang, and P.J. Russell Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression Prostate Cancer Prostatic Dis. 6 2003 174 181 (Pubitemid 36798388)
68. A. Marreiros, R. Czolij, G. Yardley, M. Crossley, and P. Jackson Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53 Gene 302 2003 155 164 (Pubitemid 36078407)
69. W. Liu KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NF{kappa}B complex in human prostate cancer J. Biol. Chem. 286 2011 18949 18959
70. C. Duriez, N. Falette, U. Cortes, C. Moyret-Lalle, and A. Puisieux Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage Oncogene 19 2000 2461 2464 (Pubitemid 30323480)
71. Q. Wu Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells Cell Tissue Res. 314 2003 237 249 (Pubitemid 37452690)
72. S. Lebel-Binay, C. Lagaudriere, D. Fradelizi, and H. Conjeaud CD82, tetra-span-transmembrane protein, is a regulated transducing molecule on U937 monocytic cell line J. Leukoc. Biol. 57 1995 956 963
73. J.H. Kim Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis Nat. Cell Biol. 8 2006 631 639 (Pubitemid 43827357)
74. B. Kim Identification of the KAI1 metastasis suppressor gene as a hypoxia target gene Biochem. Biophys. Res. Commun. 393 2010 179 184
75. K. Salnikow, T. Davidson, Q. Zhang, L.C. Chen, W. Su, and M. Costa The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis Cancer Res. 63 2003 3524 3530 (Pubitemid 36793031)
76. S. Bandyopadhyay The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer Cancer Res. 66 2006 11983 11990 (Pubitemid 46094212)
77. H.J. Han, J. Russo, Y. Kohwi, and T. Kohwi-Shigematsu SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis Nature 452 2008 187 193 (Pubitemid 351380252)
78. K.S. Cannon, and P. Cresswell Quality control of transmembrane domain assembly in the tetraspanin CD82 EMBO J. 20 2001 2443 2453 (Pubitemid 32452862)
79. B. Chen, J. Mariano, Y.C. Tsai, A.H. Chan, M. Cohen, and A.M. Weissman The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site Proc. Natl. Acad. Sci. USA 103 2006 341 346 (Pubitemid 43122402)
80. K. Shimizu The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein FEBS Lett. 456 1999 295 300 (Pubitemid 29352311)
81. H. Watanabe, P. Carmi, V. Hogan, T. Raz, S. Silletti, I.R. Nabi, and A. Raz Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor J. Biol. Chem. 266 1991 13442 13448 (Pubitemid 21907364)
82. S. Fang, M. Ferrone, C. Yang, J.P. Jensen, S. Tiwari, and A.M. Weissman The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum Proc. Natl. Acad. Sci. USA 98 2001 14422 14427 (Pubitemid 33121407)
83. B. Joshi, L. Li, and I.R. Nabi A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase J. Biol. Chem. 285 2010 8830 8839
84. M.Q. Li, X.F. Hou, S.J. Lv, Y.H. Meng, X.Q. Wang, C.L. Tang, and D.J. Li CD82 gene suppression in endometrial stromal cells leads to increase of the cell invasiveness in the endometriotic milieu J. Mol. Endocrinol. 2011 JME-10-0165